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BACKGROUND: The molecular basis of human testicular dysfunction is largely unknown. Global gene expression
profiling of testicular biopsies might reveal an expression signature of spermatogenic failure in azoospermic men.
METHODS: Sixty-nine individual testicular biopsy samples were analysed on two microarray platforms; selected
genes were validated by quantitative real-time PCR and immunohistochemistry. RESULTS: A minimum of 188 tran-
scripts were significantly increased on both platforms. Their levels increased with the severity of spermatogenic
damage and reached maximum levels in samples with Sertoli-cell-only appearance, pointing to genes expressed in
somatic testicular cells. Over-represented functional annotation terms were steroid metabolism, innate defence
and immune response, focal adhesion, antigen processing and presentation and mitogen-activated protein kinase
K signalling pathway. For a considerable proportion of genes included in the expression signature, individual tran-
script levels were in keeping with the individual mast cell numbers of the biopsies. When tested on three disparate
microarray data sets, the gene expression signature was able to clearly distinguish normal from defective spermato-
genesis. More than 90% of biopsy samples clustered correctly into the corresponding category, emphasizing the
robustness of our data. CONCLUSIONS: A gene expression signature of human spermatogenic failure was revealed
which comprised well-studied examples of inflammation-related genes also increased in other pathologies, including
autoimmune diseases.
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Introduction
Male infertility is a major health problem affecting 15% of
couples during their reproductive lifespan worldwide. Thera-
pies are ineffective in a majority of the cases, and a growing
number of patients undergo testicular biopsy for testicular
sperm extraction (TESE) and ICSI into an oocyte. To date, his-
tological examination of the biopsies is the only way to obtain
diagnostic and prognostic information to devise appropriate
medical treatment (for review, see Schulze et al., 1999;
McLachlan et al., 2007). Sequencing of the human genome
has profoundly affected the way in which pathologies are
studied, spawning the development of high-throughput tech-
nologies such as gene expression profiling using high-density
DNA microarrays. This method is now widely employed in
the diagnosis of cancer and other potentially fatal human dis-
eases (Alizadeh et al., 2000; Bittner et al., 2000; Perou et al.,
2000). Gene expression profiling is also likely to improve the
diagnosis of male infertility and to promote individualized
therapy design (He et al., 2006).
To date, few studies have used global expression profiling to
assess the molecular phenotypes of the normal and pathological
human testis (Fox et al., 2003; Rockett et al., 2004; Yang et al.,
2004; Ellis et al., 2007). However, in some of these publi-
cations the use of divergent grading systems, small biopsy
numbers and pooling of samples make it difficult to interpret
the results. Also, considering the heterogeneity of human testi-
cular pathologies, the analysis of additional individual patho-
logical and morphological subtypes is essential. We recently
employed microarray analysis to reveal distinct subtypes of
spermatogenic failure in humans (Feig et al., 2007). In this
approach, the selection of defined and histologically uniform
subtypes, combined with the analysis of individual biopsy
samples, was a crucial step. The pathological subtypes imply
that the seminiferous tubules lack germ cells, and hence the
corresponding cell type- and stage-specific transcripts, in a
varying degree. We exploited this observation to reveal†A.N.S. and C.F. contributed equally.
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subtype-specific expression profiles which could be correlated
with specific stages of human male germ cell development
(Feig et al., 2007). The vast majority of the differentially
expressed transcripts were indeed testis- or even germ cell-
specific, reflecting reduced numbers of the corresponding
germ cells which normally express these mRNAs.
To reveal transcriptional changes occurring in testicular
non-germ cells, we here focused on transcripts which increased
during defective or absent spermatogenesis. These transcripts
are likely to reflect changes in the somatic cells, and might
reveal target genes for interventional therapy (for review, see
He et al., 2006). During routine diagnostic work-up of
human testicular biopsies, the somatic cell types are often not
further analysed because the focus is on germ cells.
However, perturbed functions of Sertoli cells, peritubular
myoid cells, interstitial Leydig cells and immune cells are
known to accompany and may even cause spermatogenic
failure. Infiltration of mast cells (Jezek et al., 1999; Yamanaka
et al., 2000), interstitial fibrosis (Frungieri et al., 2002) as
well as an altered distribution and/or dysfunction of Leydig
cells (Tash et al., 2002; Holm et al., 2003; de Kretser, 2004;
Andersson et al., 2004) are frequently associated with testicular
pathology (for review, see McLachlan et al., 2007).
To be able to correlate the highly individual gene expression
patterns of human testicular biopsies with distinct pathological
subtypes, we analysed samples belonging to four frequently
observed and uniform subtypes, termed ‘normal spermato-
genesis’, ‘uniform hypospermatogenesis’, ‘maturation arrest
of germ cells at meiosis’ and ‘Sertoli-cell-only appearance’.
Using two different oligonucleotide microarray platforms
(Codelink and GeneChip arrays), we filtered 188 genes which
showed significantly increased expression in the pathological
subtypes, whereby the individual transcript levels increased
with the severity of the pathology and also with the individual
mast cell numbers of the biopsies. The validity of the gene
expression signature was further confirmed by an integrated
analysis of three independent microarray data sets. The mol-
ecular changes revealed hallmarks of a graded inflammatory-
like response and might point to novel therapeutic targets.
Materials and Methods
Patients and testicular biopsies
Testicular biopsies were obtained from patients presenting at the
Department of Andrology, University Hospital Hamburg-Eppendorf,
Germany, between August 2004 and June 2006. Informed consent
and Ethic Committee Approval was obtained (OB/X/2000), and the
study conducted in accordance with the guidelines of the ‘Helsinki
Declaration’. Tissues were taken simultaneously for therapeutic
TESE and diagnostic purposes as described previously (Jezek et al.,
1998; Schulze et al., 1999; Feig et al., 2007). For the present study,
69 samples were selected from a collective of 700. Their histology
was extrapolated from examinations of parallel biopsies from the
same testis as part of the routine diagnostic work-up. As a final selec-
tion step, results from a test-TESE were taken into account to exclude
any discrepancies between the morphological classification of the first
biopsy and the spermatogenic activity in a second biopsy from another
area of the same testis (compare Feig et al., 2007). Most patients had
bilateral biopsies, and care was taken that the selected parallel samples
were always from the same side.
RNA preparation
Tissue samples of rice grain size were removed and immediately sub-
merged in RNAlaterw (Ambion, Austin, TX, USA). Total RNA was
extracted in RNApureTM (Peqlab, Erlangen, Germany) and re-purified
on RNeasyTM columns (Qiagen, Hilden, Germany) according to the
manufacturers’ protocols as described (Feig et al., 2007). Purity and
integrity (28S/18S ratio) were assessed by loading 200 ng aliquots
onto RNA 6000 nano assay chips using an Agilent Bioanalyzer
(Model 2100; Agilent Technologies, Palo Alto, CA, USA). Only
samples with an RNA integrity number higher than 7.5 (RIN,
Agilent software) were included in the analyses.
Complementary RNA target synthesis and hybridization of
Codelink bioarrays
2 mg of total RNA per reaction were employed in reverse transcription
as described (Feig et al., 2007). After second-strand synthesis, the
complementary DNA (cDNA) served as template for time-optimized
in vitro transcription using T7 RNA Polymerase to produce target
RNA with the CodeLinkTM expression assay reagent kit (GE Health-
care, Piscataway, NJ, USA). Concomitant labeling in the presence of
biotinylated nucleotides (Biotin-16-UTP, Roche, Switzerland),
column-purification, UV spectrophotometry quantification and
hybridization to CodelinkTM Human 20K Bioarrays (GE Healthcare)
was performed as described (Feig et al., 2007). Slides were dried
and scanned on a 428TM Array Scanner (Affymetrix, Santa Clara,
CA, USA) using Jaguar 2.0 Software. CodeLinkTM Expression Analy-
sis Software v4.1 (GE Healthcare) was used for image analysis.
Complementary RNA target synthesis and hybridization
of Affymetrix GeneChips
Amplification and biotin labeling of complementary RNA (cRNA)
was performed following the Eukaryotic Sample and Array Processing
Manual (Affymetrix; Schlecht et al., 2004). Briefly, 2 mg of total RNA
were used for reverse transcription using the One-Cycle cDNA
Synthesis Kit (Affymetrix). After second-strand synthesis, the
cDNA served as template for in vitro transcription using the IVT
Labeling Kit (Affymetrix) to produce cRNA in the presence of
biotin-conjugated nucleotide analogues (16 h, 378C). Following
amplification and purification, cRNA targets were incubated at 948C
for 35 min and the resulting fragments monitored on the BioAnalyzer
(Agilent). Hybridization cocktails containing fragmented cRNA at a
final concentration of 0.05 mg/ml were transferred into Human
Genome U133 Plus 2.0 Array GeneChips (Affymetrix) and incubated
for 16 h at 60 U/min at 458C on a rotator (Affymetrix Hybridization
Oven 640). Arrays were washed and stained by using a streptavi-
dine–phycoerythrin conjugate. To increase signal strength, the anti-
body amplification protocol was used (EukGE-WS2v4; Eukaryotic
Sample and Array Processing Manual). GeneChips were processed
with a HP GeneArray Scanner (Affymetrix) by using default settings.
DAT image files of the microarrays were generated using Microarray
Analysis Suite 5.0 (MAS; Affymetrix).
Data analysis and statistics
After elimination of genes below background levels (Codelink: esti-
mated from 300 negative bacterial control spots; GeneChip: the fifth
percentile of all expression values) and imputation of missing values
by a k-nearest neighbour (KNN) approach (Troyanskaya et al., 2001),
datasets were normalized by quantile normalization (R package ‘affy’).
This approach yielded 17 093, 17 949 and 23 822 genes for the Codelink
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training and test datasets and for the GeneChip dataset, respectively. In
compliance with the MIAME (Minimal Information to Annotate a
Microarray Experiment) guidelines (Brazma et al., 2001), raw and pro-
cessed data files of all specimens were deposited in the Gene Expression
Omnibus (‘Codelink training set’, GSE4797; ‘Codelink test set’,
GSE6023) and ArrayExpress (‘GeneChip set’, E-TABM-234) public
repositories. Defining four morphological subgroups, differential genes
were selected by analysis of variance (ANOVA) and the ‘Bonferroni’
value as the most conservative statistical cut-off (2.93E-6 for Codelink;
2.1E-6 for GeneChip) was employed. Pair-wise individual t-tests were
performed between the groups in order to elucidate different profiles
within the gene list. Hierarchical clustering (average distance, Manhattan
metric) was performed on the individual samples or on medians of the
subgroups using all genes. Cluster stability was evaluated using multi-
scale permutation clustering (R package ‘pvclust’; Suzuki and
Shimodaira, 2006). Scaled and centered data were subjected to Principle
Component Analysis (PCA, R package ‘ade4’). The transformed values
were additionally analysed using partitioning around medoids (PAM) as
implemented in R (package ‘cluster’). The significance of PAM results
after several rounds of analysis using increasing numbers of clusters
was verified by using silhouette plots which are to some extent a
measure of the degree of similarity of expression patterns in a given
cluster compared with all other patterns in the other clusters.
Creation and analysis of the combined data set
Systematic bias reduction was achieved as described by Benito et al.
(2004) by using the Java implementation of Distance weighted
discrimination (DWD) (https://genome.unc.edu/ pubsup/dwd/
DWD.zip). DWD processed datasets were merged and subjected to
hierarchical clustering as described above. Stringent classification of
all samples was conducted by Diagonal Linear Discriminant Analyis
(DLDA), KNN and Support Vector Machines (SVM) using
Leave-One-Out-Cross-validation with 2000 permutations of the
class labels for a more realistic estimate of the misclassification rate
(BRB ArrayTools v.3.4). All scripts used in this analysis can be down-
loaded from http://humrep.oxfordjournals online.
Quantitative RT–PCR analyses
cDNA synthesis followed standard procedures as described in
Feig et al. (2007). Primers were designed using free Primer 3 software
(http://frodo.wi.mit.edu/); sequences are available as Supplemental
information (Supplementary Data S8). Quantitative RT–PCR
(qRT–PCR) was performed using LightCyclerTM (Roche, Basel,
Switzerland) technology. The threshold cycle (crossing point) was
determined for each reaction by second derivate maximum method
(LightCyclerTM Quantification Software). Transcript levels were nor-
malized to ribosomal protein S27 RNA showing minimum variation
between individual samples. Fold differences were calculated by use
of the relative expression software tool (REST# software, Pfaffl
et al., 2002). PCR efficiency was in the range between 1.65 and
1.81 as calculated by an R script employing the window-of-linearity
method (Ramakers et al., 2003). Products were gel separated and
their identity verified by sequence analysis.
Immunohistochemistry
Tissue sections were prepared from Bouin-fixed, paraffin-embedded
fragments of testicular biopsies. Anti-calretinin antibody-Zymed,
polyclonal from rabbit (Invitrogen, Karlsruhe, Germany) was
employed to stain slides at a dilution of 1:100. Antigen localization
was achieved using a two-step immunoperoxidase staining method
(Envision plus polymer System, DAKO; Hamburg, Germany). Speci-
ficity of immunostaining was confirmed by both, omission of primary
antibody and staining of parallel sections with antibodies directed
against an irrelevant antigen. Stained sections were evaluated by
bright-field microscopy (Nikon, Du¨sseldorf, Germany) and images
captured with a Leica DC 300 digital camera (Leitz, Bensheim,
Germany).
Counting of mast cells
Testicular mast cell numbers were estimated from 28 diagnostic semi-
thin sections, which had been prepared for diagnostic work-up from
plastic-embedded parallel biopsies of the same testes included in the
Codelink 28-sample training set. Metachromatic granula-positive
cells were counted by two people in four independent fields-of-view
in an independent and blinded fashion as described in Jezek et al.
(1999). Differences between samples from different histological sub-
groups were calculated with a total of 12 different statistical tests for
distribution, location, variance and scale to obtain an overview of the
characteristics underlying individual mast cell counts (Supplementary
Data S7). In the case of a normal distribution, parametric tests were
applied (e.g. t-test). In any other case, non-parametric versions of
the tests were used (e.g. Wilcoxon rank-sum test).
Over-representation analysis
Over-represented GO (gene ontology) terms and pathways were
queried using the DAVID 2007 server (http://niaid.abcc.ncifcrf.
gov/). Genes were queried for the over-representation of transcription
factor binding sites (TFBS) by using the OPOSSUM web tool version
1.3 (http://www.cisreg.ca/cgi-bin/oPOSSUM/ opossum) with
default settings.
Results
Filtering of genes induced in testicular pathology
The 69 analysed biopsies belonged to four distinct histological
subtypes termed normal spermatogenesis, uniform hyposper-
matogenesis, maturation arrest of germ cells at meiosis
(‘germ cell arrest’) and Sertoli-cell-only appearance
(compare Feig et al., 2007). Only samples with uniform his-
tology and conformity of test-TESE results were included
(see Materials and Methods). Cases with obvious morphologi-
cal differences between individual seminiferous tubules in
different areas of the testis were excluded. The sample set
contained biopsies from vasectomized men which may exhibit
testicular changes (compare Raleigh et al., 2004). However,
histological inspection confirmed qualitatively and quantitat-
ively normal spermatogenesis in each of the selected cases,
and, importantly, a previous microarray analysis clustered
them together with other samples of normal spermatogenesis.
Three sample sets were grouped from the 69 biopsies and
individual gene expression patterns assessed in independent
laboratories on two microarray platforms. The Codelink train-
ing set comprised 28 samples (GSE4797). An equivalent,
but independent, GeneChip set comprised 27 samples
(E-TABM-234). An additional set of 14 samples was indepen-
dently analysed on the Codelink platform (GSE6023) and the
data included only later as a test set (see below). Comparable
analysis procedures were applied to both data sets (see
Materials and Methods). The overall distributions of ratios
from all transcripts were calculated between histological sub-
types to assess whether a reduction in germ cell numbers
might cause an overall proportional enrichment of somatic
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transcripts. This procedure provides more information about
changes in cellular distribution compared with a normalization
based on erroneously selected somatic genes that might be
potentially regulated. Comparing normal spermatogenesis
and hypospermatogenesis, a mean ratio near 1 was observed
with both platforms (1.05+ 0.35 and 1.08+ 0.40, respec-
tively), suggesting that overall changes in transcript pro-
portions were negligible between these subtypes. In
comparison, mean ratios of .1 were noticed between normal
spermatogenesis and germ cell arrest (1.12+ 0.48 and
1.24+ 0.70, respectively), and also between normal spermato-
genesis and Sertoli-cell-only appearance (1.35+ 0.91 and
1.58+ 1.50, respectively). This observation corroborated his-
tological data indicating such an effect.
To filter the differentially expressed genes, adjusted cut-off
values for fold induction were chosen that took into account
the effects of non-germ cell enrichment and differences
between dynamic range (sensitivities) of the array platforms
(Supplementary Fig. S1; compare MAQC consortium, 2006).
Using the stringent ‘Bonferroni’ threshold level for P-values
(ANOVA) and a fold induction .2 in any one of the three
pathological subtypes, 551 differential Codelink genes were fil-
tered which showed significantly increased transcript levels in
spermatogenic failure compared with normal spermatogenesis
(see Supplementary Data S1). In the GeneChip system,
2096 differential probe sets were filtered which showed a
minimum fold induction of 3 (see Supplementary Data S2).
The higher number of genes detected by GeneChips can in
part be explained by the fact that they covered more genes
than the Codelink arrays.
Characteristics of gene expression profiles
Mean transcript levels of differential genes were calculated for
each morphological subtype and plotted to illustrate their
expression profiles in correlation with these subtypes. The
line plots showed similar profiles on both platforms, reflecting
a graded induction in correlation with increased spermatogenic
damage (Fig. 1, panel A). A significant increase was observed
between normal spermatogenesis and hypospermatogenesis,
and again between germ cell arrest and Sertoli-cell-only
appearance. Maximum transcript levels were most often
correlated with Sertoli-cell-only appearance. In hypospermato-
genesis and germ cell arrest, fold inductions were often
considerably smaller. Quantitative differences between the
latter two pathologies, however, were not significant for most
loci (Fig. 1, panel B). As a consequence, we were unable to
identify any induced genes that discriminated hypospermato-
genesis from germ cell arrest with sufficiently high accuracy.
We also failed to detect any transcripts which showed
significant increase in hypospermatogenesis and/or germ cell
arrest, but not in Sertoli-cell-only appearance.
Based on the independent Codelink and GeneChip lists,
supervised hierarchical clustering was employed to group the
samples in four categories, as suggested from the histological
subtypes. Stable clusters of normal spermatogenesis and
Sertoli-cell-only appearance were revealed (Supplementary
Figs 2 and 3). As opposed to these, samples which showed
hypospermatogenesis and germ cell arrest were not clearly
separated, but clustered in near vicinity within the dendro-
grams, pointing to a higher intra-group variability and related-
ness in terms of their pathology-induced genes. The tendency
of samples to group into three categories instead of four is
also illustrated by PCA (Supplementary Figs 2C and 3C).
The PAM cluster algorithm was additionally applied to
group the differential GeneChip genes by their similarity of
expression profiles in order to possibly identify additional pro-
files of gene induction. A cluster of 278 Affymetrix probe sets
showed a robust increase in the pathological samples (Sup-
plementary Data S3). Again, the individual expression profiles
reflected a graded induction of the differential genes, their tran-
script levels increasing with increased germ cell loss and reach-
ing maximum levels in Sertoli-cell-only appearance. No other
PAM clusters of pathology-induced genes were revealed,
suggesting that in the histological subtypes studied here, any
genes showing divergent profiles of induction were extremely
rare, if at all present.
Confirmation of pathology-associated molecular
alterations
Linking annotations from both the Codelink and GeneChip lists
of differential genes was achieved by conversion into UniGene
cluster IDs (UCIDs, Unigene Build #190). An intersection of
188 common UCIDs was apparent (Fig. 2A; Supplementary
Data S4). As the differential gene lists had been independently
filtered, this overlap validated our results. Based on the PAM
algorithm, the number of intersecting genes was smaller, but
the overlap was still substantial. When genes from the central
most intersection of the Venn diagram were inspected more
closely (Fig. 2A), it turned out that they comprised well-known
examples of pathology-related genes (compare Table 1) which
had previously been shown to be induced in various human
pathologies. These genes were characterized by robust fold
inductions in all subtypes of defective spermatogenesis,
showing ~2-fold increase in expression levels even in
hypospermatogenesis (Table 1).
To further validate the array data, qRT–PCR was performed
employing cDNAs from all 28 samples of the Codelink training
set. Twenty genes were selected from the independent gene lists,
comprising known and as yet uncharacterized loci (partially
shown in Fig. 3; Supplementary Fig. S4; for oligonucleotide
primers, see Supplementary Data S8); in all cases except one
(GAK; NM_005255) their increase was confirmed by qRT–
PCR. In addition, the profiles obtained by microarray and
qRT–PCR expression analyses were in good agreement
(Fig. 3). A significant increase of the LH receptor (LHCGR)
transcripts was suggested by our data from GeneChips. The
gene was not covered by the Codelink array, and thus was not
included in the intersection. Still, using the cDNAs from the
Codelink samples, the increase was confirmed by qRT–PCR
(Fig. 3). Maximum transcript levels of the Leydig cell-specific
gene were observed in Sertoli-cell-only appearance; a fold
induction clearly above our threshold criteria, however, was
also suggested for hypospermatogenesis and germ cell arrest.
Since cell type-specific transcripts are increased as the rela-
tive proportion of that specific cell type increases, we looked
at genes well known to be specifically expressed in somatic
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testicular cells. Interestingly, many of these were not included
in the lists of differentially expressed genes. This group com-
prised Sertoli cell-specific reference genes such as the Wilms
tumour suppressor WT1 (NM_024426), testis-specific kinase
TESK2 (NM_007170; Toshima et al., 2001), Anti-Mu¨llerian
hormone AMH (NM_000479) and the FSH receptor FSHR
(NM_000145; compare GSE4797 and E-TABM-234 with Sup-
plementary Data S1 and S2). FSHR transcript levels were con-
firmed by qRT–PCR (data not shown), suggesting that they
were unaffected by impaired or absent sperm production in
our patients. Transcript levels of the androgen receptor gene
(AR; NM_000044), which is expressed in various somatic cell
types of the adult testis, likewise appeared unaffected by the pre-
sence or absence of germ cells.
We sought to determine whether increased transcript levels
would cause an increase on the protein level. At the same time,
we aimed to confirm that the suggested alterations in gene
expression affected the somatic testicular cell types. Immunoper-
oxidase histochemistry (IHC), although not a quantitative
method, is currently the only practical way of detecting proteins
in small fixed tissue samples. We focused on robust differences
in expression levels which might be discerned by IHC and
chose calretinin (CALB2¼ calbindin 2) as an example (see
Table 1; Fig. 4A). Abnormal calretinin expression in azoospermic
men had previously been shown by IHC (Bar-Shira Maymon
et al., 2005). Employing anti-calretinin antibodies, we compared
histological sections of different histological subtypes. Immunos-
taining of the protein was seen in all subtypes, including normal
spermatogenesis, where it appeared to be restricted to the
Leydig cells (Fig. 4B), at the same time providing an internal
positive control. Sections of biopsies with Sertoli-cell-only
appearance revealed an increase in interstitial staining as well
as an additional staining within isolated seminiferous tubules
(Fig. 4C), most probably originating from Sertoli cells
(compare Bar-Shira Maymon et al., 2005).
Functional annotations of pathology-induced genes
Gene annotation enrichment analysis was applied to the lists of
differential genes to reveal functional categories over-
represented relative to chance (Fig. 2, panel B; Supplementary
Data S1–S4). Categories common to both independent Code-
link and GeneChip lists included lipid/steroid metabolism, posi-
tive regulation of nuclear factor (NF)-kB cascade, focal
adhesion and the mitogen-activated protein kinase (MAPK) sig-
nalling pathway (Fig. 2, panel B). Over-representation of
NF-kB TFBSs in the promoter regions of the induced genes
pointed to a potential pathological role of this pro-inflammatory
pathway. When only the 188 intersecting genes were considered
(compare Supplementary Data S4), over-representation of
innate defence and immune response, antigen processing and
presentation and NO signalling was observed (Fig. 2, panel
B). In the PAM gene list, complement activation, androgen
metabolism, innate and humoral immune response, complement
and coagulation cascades and xenobiotic metabolism were
additional over-represented functional categories.
Annotations and survey of the literature suggested that a
considerable proportion of robustly increased transcripts were
mast cell-derived. These included TPSAB1 and CPA3, encod-
ing mast cell-specific proteases secreted from the granules
upon activation (compare Table 1) and also FCER1G
Figure 1: (A) Line plots of genes significantly induced in human testicular pathology
Expression profiles of 551 probes (Codelink, upper panel) and 2096 probe sets (GeneChip, lower panel) showed high correlation between increas-
ing transcriptional activity and testicular pathology. Their common characteristic is a statistical significance in the transcriptional changes, which
is below the ‘Bonferroni’ cut-off. The grey lines depict transcriptional profiles, while the black box plots illustrate the median and interquartile
ranges from four different pathological subtypes. FTS, full testicular spermatogenesis; GCA, germ cell arrest; HYS, hypospermatogenesis; SCO,
Sertoli-cell only. (B) P-value distribution of all probes (histograms) for the transcriptional changes within FTS/HYS, HYS/GCA and GCA/SCO,
respectively, as calculated by t-test. Note the high statistical significance of transcriptional changes between FTS and HYS and also between GCA
and SCO
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(NM_004106), encoding the mast cell-specific immunoglobu-
lin (Ig)E-receptor. Additional gene products were contained
in the list of differential genes, which had previously been
reported to increase in correlation with abnormal activation
and/or accumulation of mast cells (and other immune cells).
We therefore asked whether certain transcript levels were in
keeping with the mast cell numbers in the testicular biopsies.
Mast cells are readily detectable as metachromatic granula-
positive cells on histological sections (Jezek et al., 1999).
They were counted using slides from parallel biopsies to the
Codelink samples. Applying parametric or non-parametric stat-
istics, depending on the normal distribution of the cell counts, a
significant increase in mast cell number was seen between
normal spermatogenesis and Sertoli-cell-only appearance
(P , 0.001), and further between normal spermatogenesis
and hypospermatogenesis (P, 0.01; Supplementary Data
S7; Supplementary Fig. S5).
To reveal correlations between individual transcript levels
and individual numbers of metachromatic granula-positive
cells, a logistic regression approach was conducted on each
of the 551 differential Codelink genes (Supplementary Data
S5). A total of 310 Codelink genes (.60%) were revealed
with individual transcript levels correlating directly at P ,
0.05 with the corresponding metachromatic granula-positive
cell numbers. In comparison, when the data were adjusted for
individual patients’ serum levels of LH, FSH and testosterone
as further possible factors which might affect testicular tran-
script levels, the numbers of genes correlating at the same
P-value were much lower, i.e. 9, 5 and 28 with individual
serum LH, FSH and testosterone levels, respectively.
Cross-platform sample classification
In order to evaluate the potential general significance of
the gene expression signature, the expression data of all 69
Figure 2: (A) Venn diagram showing overlap of genes between three datasets obtained from the Codelink training set, the GeneChip dataset
based on the same analytical approach as the former, and a third dataset obtained from supervised partitioning around medoids (PAM) clustering
of the GeneChip dataset
‘Probes’ refers to the differential signals from distinct hybridization probes, UniGene cluster IDs (‘UCIDs’) to the number of non-redundant
UNIGENE clusters. Numbers in intersections refer to common non-redundant UNIGENE clusters. (B) Hierarchical representation of Gene Ontol-
ogy and pathway terms over-represented in the datasets and intersections. Terms in blue, green and magenta are obtained from the Codelink, the
GeneChip and the GeneChip PAM analysis, respectively. Common terms of the intersection are in red with underlines. Listed are all terms with
P-values P, 0.05 after multiple testing correction. MAPK, mitogen-activated protein kinase; ECM, extracellular matrix
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biopsy samples were merged into a single data set. Gene anno-
tations were converted into UCIDs and multiple occurrences of
the same UCID removed by calculating its median value within
each experiment and platform. After probe matching, a total of
406 UCIDs was retained from the initially elaborated Codelink
list (Supplementary Data S6). To adjust for systematic biases,
DWD (Benito et al., 2004) was applied in a pair-wise fashion
by first combining the 28-sample Codelink training set with
additional 14 samples from the Codelink test set, and then com-
bining this common set with the 27-sample GeneChip data set
(Supplementary Fig. S6). Based on the 406 Codelink genes,
hierarchical cluster analysis was applied to the integrated
data set, resulting in a separation into three categories
(Fig. 5, upper panel), similar to the dendrogram structures pre-
viously seen in the independent data sets from both platforms
(see Supplementary Figs 2 and 3). This implied that the gene
expression signature was valid in different sample collectives
and patient cohorts which had been assayed with different
array platforms.
Referring to the proposals of Dupuy and Simon (2007), we
additionally applied three stringent statistical classification
methods to the dataset. For this approach, only two alternative
categories were distinguished, i.e. ‘pathological’, comprising
hypospermatogenesis, germ cell arrest and Sertoli-cell-only
appearance, and ‘normal’, comprising all samples with
quantitatively and qualitatively complete spermatogenesis.
Each of DLDA, KNN and SVM was subjected to
Leave-One-Out-Cross-validation and 2000 permutations of the
class labels in order to obtain a more realistic estimate of the mis-
classification rate (Fig. 5, lower panel). All Sertoli-cell-only
samples (n ¼ 17) and all samples with normal spermatogenesis
(n ¼ 21) were correctly classified. In addition, the majority of
samples with hypospermatogenesis and germ cell arrest were cor-
rectly classified as ‘pathological’ samples. In four cases, a mis-
classification pattern was coherent throughout the different
algorithms. In summary, an overall correct sample classification
rate of 94.2% was achieved with this more stringent set-up.
Discussion
Microarray data from 69 human testicular biopsies revealed a
gene expression signature of spermatogenic failure, which
resembled the graded induction of an inflammatory-like
response. Approximately 2–3% of testicular transcripts were
increased in the pathological samples, their levels gradually
growing with the severity of spermatogenic damage and reaching
maximum levels in samples with Sertoli-cell-only appearance.
As anticipated, germ cell-specific transcripts were not included.
These results underscore our previous observation that two fun-
damentally different patterns of coordinated gene expression
Table 1: Genes showing robust fold increase (Codelink/GeneChip) between normal spermatogenesis and three subtypes of spermatogenic failure (SCO, GCA
and HYS)
Gene
abbreviation
Accession
number
Name of protein Functional role (known or assumed);
association with disease
Ratio, SCO Ratio, GCA Ratio, HYS
CPA3 NM_001870 Carboxypeptidase A3 Mast cell-specific protease; induced in
asthma and allergic inflammation
8.64/10.19 2.62/2.08 2.65/1.98
CALB2 NM_001740 Calretinin ¼ Calbindin 2 Calcium-binding protein; cancer-associated,
induced upon mast-cell activation and in
azoospermia
7.40/6.03 2.75/3.14 1.70/2.70
LDLR NM_000527 Low density lipoprotein receptor Lipoprotein binding and endocytosis;
dysfunction causes familial
hyper-cholesterolemia; increased in
inflammation
7.13/3.94 3.54/3.19 3.03/1.90
CLEC2B NM_005127 C-type lectin domain family 2,
member B
Activating receptor; associated with
myolocyte/lymphocyte infiltration and
activation
5.93/6.57 2.12/3.33 2.13/2.46
TPSAB1 NM_003294 Tryptase alpha/beta Mast cell-specific protease; induced in
inflammation and mast cell-associated
fibrosis
5.52/8.71 2.83/2.12 2.02/1.76
SAMD9L NM_152703 Sterile alpha motif domain
containing 9-like
Extraosseous calcification; associated with
atherosclerosis and autoimmune disorders
5.24/10.33 1.76/2.46 1.99/1.63
DPT NM_001937 Dermatopontin Extracellular matrix protein; increased in
fibrotic diseases and infection
4.50/9.09 2.23/3.49 2.12/3.36
RBP1 NM_002899 Cellular retinol binding protein-1
(CRBP1)
Vitamin A homeostasis protein; increased in
liver fibrosis/cirrhosis and prostate cancer
4.42/6.21 2.70/2.24 1.97/3.12
CTSC NM_133504 Cathepsin C ¼ Dipeptidyl peptidase
I (DPPI)
Lysosomal protease; increased in sepsis,
arthritis, allergic inflammation
4.29/19.99 2.38/3.36 2.17/3.57
ADAMTS5 NM_007038 A disintegrin-like and
metalloprotease with
thrombospondin type 1 motif, 5
Metalloprotease; involved in degradation of
cartilage aggrecan (aggrecanase-2); induced
in osteoarthritis
4.09/4.91 2.14/2.34 2.32/1.91
TNFSF13B NM_006573 Tumour necrosis factor (ligand)
superfamily, member 13b (¼
BAFF)
B cell activating factor; over-expressed in
pathogenesis and progression of
autoimmune diseases
3.59/7.00 1.70/2.73 1.91/2.13
C1orf24 ¼
FAM129A
NM_052966 NIBAN protein with
pleckstrin-homology and armadillo
repeat domains
Unknown function; thyroid
cancer-associated
3.04/9.64 2.56/6.12 2.34/2.36
GCA, germ cell arrest at meiosis; HYS, hypospermatogenesis; SCO, Sertoli-cell-only appearance.
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are correlated with testicular pathologies (compare Feig et al.,
2007). The first and most obvious pattern corresponded to the
degree of successful spermatogenesis in each individual sample
and comprised predominantly germ cell-specific genes. The
second pattern which was analysed here corresponds to patho-
logical changes in testicular non-germ cells. A similar pattern
was recently described in human testicular biopsies by Ellis
et al. (2007) who also observed a pathology-associated increase
in transcript levels which corresponded to inflammatory activity.
The molecular changes observed in our study were accompanied
by extensive tissue remodelling and by an infiltration or acti-
vation of immune cells, including mast cells, in the testicular
interstitium. Lipid/steroid metabolism, immune response, posi-
tive regulation of NF-kB cascade, focal adhesion and MAPK sig-
nalling pathway were over-represented functional categories,
pathways known to be persistently activated in various other
disease states involving inflammation, allergy and autoimmunity
(for review, see McCulloch et al., 2006). In the testis, such path-
ways have been implicated in germ cell apoptosis (Pentikainen
et al., 2002; Rasoulpour and Boekelheide, 2007) and
ischemia-reperfusion (Lysiak et al., 2005). They may also be a
key event in autoimmune orchitis (compare Starace et al., 2005).
Stereological studies in men with impaired spermatogenesis
showed altered Leydig cell distribution (Tash et al., 2002;
Holm et al., 2003). The proportion of the testis parenchyma
occupied by Leydig cells was significantly larger, although
the absolute Leydig cell content seemed to be reduced. From
our study, increased transcript levels of various Leydig cell
markers, including the LHCGR, was suggested, possibly
reflecting a proportional increase in Leydig cells in the patho-
logical samples. On the other hand, spermatogenic damage
may be associated with impaired Leydig cell functions
(Andersson et al., 2004). An increase in Leydig cell markers
thus could likewise reflect dysfunction, possibly caused by a
disturbed paracrine communication between seminiferous
tubules and interstitium which may be ultimately triggered
by impaired germ cell functions (for review, see de Kretser,
2004).
Fibrosis of the interstitium and/or fibrotic thickening in the
lamina propria is frequently associated with impaired spermato-
genesis (de Kretser and Baker, 1996), suggesting that dysregu-
lation of extracellular matrix (ECM) homeostasis is a common
feature in human testicular pathology. We observed a robust
increase in the pathological samples of transcripts encoding der-
matopontin (DPT) and various types of collagen (COL3A1,
COL4A6, COL6A3 and COL27A1) which is in line with
these observations. In vitro studies suggested the basement
membrane collagens and mast cell-derived tryptase to be key
players in testicular fibrosis, stimulating fibroblast proliferation
and increased deposition of ECM material (Frungieri et al.,
2002). We found that transcripts encoding mast cell tryptase,
mast cell carboxypeptidase, aggrecanase-2 and cathepsin C
were significantly induced in all pathological samples. These
enzymes are involved in protease-mediated remodelling
during pathological and degenerative processes in various
tissues and organs (for review, see Laprise et al., 2004; Mar-
shall, 2004; Karsenty, 2005; Hallgren and Pejler, 2006).
Enhanced extracellular occurrence in the testis thus would be
likely to cause severe tissue damage and/or ECM remodelling.
Figure 4: Validation of microarray data for calretinin (¼calbindin 2,
CALB2) on transcript (A) and protein (B and C) level
(A) qRT–PCR was applied to the same 28 CodelinkTM samples as
used for microarray hybridization (with n ¼ 12, 6, 5 and 5 for the
four pathological subtypes, respectively). Box plots showing fold
inductions (with respect to FTS) for HYS (Bars 1 and 2), GCA
(Bars 3 and 4) and SCO ratios (Bars 5 and 6). Blue: microarray
results; white: qRT–PCR results. The c.v. was under 5% for all
samples, hence error bars were omitted in the figure. (B) Immunoper-
oxidase staining using anti-calretinin antibody (1:100) on
paraffin-embedded fragment of selected biopsy showing SCO appear-
ance. (C) Immunoperoxidase staining using anti-calretinin antibody
(1:100) on paraffin-embedded fragment of selected biopsy showing
normal spermatogenesis. White arrowheads point to calretinin immu-
nostaining in interstitium; black arrow points to calretinin staining
within seminiferous tubule
Figure 3: Validation of microarray data by qRT–PCR
A comparison of four selected genes is depicted. Line plots illustrated
the good correlation in transcriptional profiles of individual genes
obtained from microarray data (black line) and qRT–PCR (grey
line). qRT–PCR was applied to the same 28 Codelink samples used
for microarray hybridization (with n ¼ 12, 6, 5, 5 for the four patho-
logical subtypes, left to right, respectively). The coefficient of vari-
ation (c.v.) was under 5% for all samples, hence error bars were
omitted in the figure
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Immune cells, including mast cells, are normal constituents
of the human testis; however, additional cells are recruited
in various testicular pathologies (for review, see Fijak and
Meinhardt, 2006). In line with a possible infiltration and/or
activation of these cells in spermatogenic failure, we see an
increase of transcripts encoding the high-affinity IgE receptor
(FCER1G; Klemm and Ruland, 2006), components of the
inflammasome (PYCARD/ASC and CASP1; for review, see
Mariathasan and Monack, 2007), the fractalkine receptor
(CX3CR1) which promotes mast cell homing and asthma
(Papadopoulos et al., 2000; Laprise et al., 2004), B-cell activat-
ing factor (TNFSF13B/ BAFF/BLyS; Claudio et al., 2002),
interleukin 32 (IL-32; Conti et al., 2007) as well as
NF-kB-activating IL-1 receptor-associated kinase (IRAK1)
(Song et al., 2006). Mast cells have been implicated in the
pathophysiology of many diverse diseases, operating through
the synthesis of pro-inflammatory mediators, the pattern of
which varies depending on tissue and stimulus (for review,
see Bischoff, 2007). They also contribute to acute testicular
inflammation (Iosub et al., 2006). The previous notion that
they may also play a role in human testicular physiology and
pathology is supported by our results.
Our analysis revealed a common gene expression signature of
spermatogenic failure characterized by the graded induction of by
and large the same genes in different pathological subgroups,
whereby the individual transcript levels closely correlated with
degree of spermatogenic damage. Based on these results one
might speculate that the different subtypes of human spermato-
genic failure represented graded manifestations of a common dis-
order, which progressively alters the functions (and numbers) of
somatic testicular cells and ultimately causes germ cell loss. Con-
versely, spermatogenic failure and germ cell loss will undoubt-
edly affect somatic testicular functions. As yet neither the
molecular mechanisms are fully understood through which the
somatic cells regulate spermatogenesis, nor are the effects of
germ cells (or conversely the loss of germ cells) on somatic
gene expression. Considering the heterogeneous aetiologies and
highly individual molecular causes which may underlie sperma-
togenic failure in the human, the molecular changes described
here may represent common symptoms, but may as well reflect
Figure 5: Hierarchical clustering of 406 genes exhibiting pathological up-regulation in the Codelink training set that were extracted from the
common set of 8263 genes in both platforms
All 69 samples were hierarchically clustered (Manhattan metric, average distance) using the colour coding as follows. The heat map was built
using all genes and heat colours from dark red (high expression) to bright yellow (low expression). Red and black dots on the dendrogram
nodes are permutation-based cluster stability P-values as calculated from the ‘pvclust’ package (red: P-value 0.05, black: P-value .0.05).
Samples are colour coded in black (FTS, F), green (HYS, H), blue (GCA, G) and red (SCO, S). Sample labels show the origin of the dataset
(FTS/HYS/GCA/SCO_X: codelink training; fts/hys/gca/sco.X: codelink test; F/H/G/S_X: geneChip). The bar coding below the heat map
was obtained with the 406 genes from a more stringent classification approach using DLDA, 1-NN and SVM, based on 2000 random permutations
of the leave-one-out cross-validation misclassification rate. Black boxes show misclassified samples (overall classification rate was 94.2%).
DLDA, diagonal linear discriminant analysis; SVM, Support Vector Machines; 1-NN, one-nearest neighbour classification
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an inherent dysfunction in the somatic testicular cell types which
may causally contribute to the pathology.
In line with this, our microarray results may have clinical
implications. They may be useful to develop new diagnostic
methods and criteria, provided that increased testicular
mRNA levels are accompanied by elevated seminal fluid
and/or serum levels of the encoded proteins. As somatic testi-
cular cells are amenable to pharmacological intervention, our
results would support anti-inflammatory therapy and/or mast
cell inhibition as promising approaches in spermatogenic
failure, at least in the less severe cases. Specifically the sub-
group of hypospermatogenic men may benefit from such treat-
ments. The results presented by Ellis et al. (2007) suggest that
they may also be applicable to cases of ‘mixed atrophy’. Thera-
peutically controlling inflammation and/or mast cell functions
can significantly improve disease outcomes (McCulloch et al.,
2006; Bischoff, 2007), although many patients remained
refractory to treatment in the past. Clinical trials in infertility
patients have likewise cast doubt on the efficacy of such thera-
pies; however, they may still be effective in a more carefully
selected subgroup of patients (‘responders’). As probably no
single target will be sufficiently effective, the future challenge
for therapy design will be to reconcile counteracting regulatory
processes which may modulate testicular functions, the NF-kB
cascade and other signalling platforms which are activated in
defective spermatogenesis representing promising targets.
Supplementary Data
Supplementary data is available at http://humrep.oxfordjour-
nals online.
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